NMS · Medical - Devices
SENS (SENS) Stock
$4.87
-0.81%
NMS: SENS
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
GlobeNewswire · Jul 21, 2026
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights
GlobeNewswire · Jul 14, 2026
DXCM Grew. The Stock Did Not. Someone Is Wrong
Trefis · Jul 10, 2026
Glucotrack Clears Key Milestone to Commercialize Its Implantable CGM
Exec Edge · Jul 8, 2026
Senseonics Holdings (SENS) Stock Fair Value Moves Lower After Analysts Cut Growth Assumptions
Simply Wall St. · Jul 1, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held12.44%
Institutions Held21.85%
Institutions Float Held24.95%
Peer Comparison
About SENS
SENS is led by CEO Timothy T. Goodnow, employs 117 people, headquartered in US, publicly traded since 2015.
SENS stock trades at $4.87 with a market capitalization of $203.54M. The stock is valued at a price-to-earnings (P/E) ratio of -3.43, price-to-book of 3.90, price-to-sales of 5.94. Over the past 52 weeks the stock has ranged between $4.79 and $12.58, and currently trades 61.3% below its 52-week high.
On profitability, SENS generates a return on equity (ROE) of -113.11%, return on capital employed of -111.48%, an operating margin of -194.29%, a net profit margin of -2.14%.